QUALITY CONTROL AND ASSURANCE OF Tc-99m GENERATORS AND KITS APPLIED IN SAEC LABORATORIES

Similar documents
After reviewing this tutorial, the user should be able to Topics to be covered

Radioisotopes production technology -EGYPT experience

Regional or Global Molybdenum-99 Supply Indian Perspective

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

PHYSICO-CHEMICAL, BIOLOGICAL OR MICROBIOLOGICAL TESTS OF MEDICINAL PRODUCTS

Draft Guidelines for Radiopharmacy

for IND and RDRC Regulated PET Compounding

Role of USP Monographs and. General Chapters. Steve Zigler, Ph.D.

REFERENCES FOR CURRENT NRC REGULATIONS: PARTS 20 AND 35.

US Regulatory Requirements: Clinical & Clinical Research Production, SPECT & PET Radiopharmaceuticals (RPs)

BG75 [ 18 F] Multi Tracer CPM Automated [ 18 F]FDG/NaF/FMISO/FLT Production & QC

Lead cation exchange and alumina columns for concentration of 99m Tc-pertechnetate

Technescan MAG3. NAME OF THE MEDICINE Technescan MAG3 Kit for the Preparation of Technetium ( 99m Tc) Mertiatide.

Bench to Bedside - The Roadmap Chemistry, Manufacturing, and Controls Issues in Radiopharmaceutical Applications

Latest USP Initiatives: Monographs, General Chapters, and Compounding

PRINCIPLES OF OPERATION

WHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory

Simplified Method for Determining the Radiochemical Purity of 99m Tc-MAG3

In the centralized radiopharmacy laboratories of hospitals,

A24 CALA Checklist for Microbiology Revision 4.1 February 16, 2018

Overview of a sterility assurance program for PET drugs

STANDARD OPERATING PROCEDURES. Handling and working with Analytical Standards

At Your ServIce. Microbiology Services. The life science business of Merck operates as MilliporeSigma in the U.S. and Canada.

European Medicines Agency Inspections

Chapter 3 Obtaining an Authorization to Possess and Use Radioactive Material

Aseptic Process Validation

Appendix-2 Country Report on Isotope Production and Its Applications

Compounding Pharmacies and the USP <71> Sterility Tests

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

INSTITUTE FOR RADIOELEMENTS YOUR SUCCESS IS OUR PASSION EXCELLENCE DEDICATED TO NUCLEAR MEDICINE, HEALTHCARE & ENVIRONMENT

University of Maryland Baltimore. Radiation Safety Procedure

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

SUMMARY OF PRODUCT CHARACTERISTICS

HISTORY AND MILESTONES

GMP and Quality Control: An Industry Perspective. Steven S. Zigler, Ph.D. PETNET Pharmaceuticals, Inc. Knoxville, Tennessee

BRIEFING 85 BACTERIAL ENDOTOXINS TEST. Portions of this general chapter have been harmonized with the corresponding texts of the European Pharmacopeia

USP Perspective on Pharmaceutical Waters. Antonio Hernandez-Cardoso, M.Sc. Senior Scientific Liaison September 7, 2017

Latest Developments in USP Monographs and the Compounding of Sterile Radiopharmaceuticals. Jim Ponto, MS, RPh, BCNP

STERILIZATION VALIDATION IN THIS SECTION REPROCESSING VALIDATIONS FOR REUSABLE MEDICAL DEVICES. Radiation Sterilization Validation

Specifications, Methods and precedence of source with particular reference to microbiological requirements in TGOs.

HardyVal TM CSP RANDOM TEST KIT

Compounding Pharmacies and Water

Pharmacopoeial Reference Standards

Good manufacturing practices

Inspection of Quality Control Laboratories

PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS

2014 Meeting of Mid-Atlantic States Radiation Control Programs

FDA s Guidance for Industry

REUSABLE MEDICAL DEVICE VALIDATION

API Stability Protocols and. Chris Byrne Tasmanian Alkaloids

Media Fill A Process Simution. Presented By Shikha Chauhan

Method Suitability Report Membrane Filtration Sterility Test with QTMicro Apparatus

Regulatory Expectations, Standards & Guidelines

Critical Environment Products and Services

CALIBRATION AND QUALIFICATION OF EQUIPMENTS IN THE PHARMACEUTICAL INDUSTRY: EMPHASIS ON RADIOPHARMACEUTICALS PRODUCTION

Identification of the need and uses of a reference standard

Medical, Pathological and Low-level Radioactive Waste Management Plan for Incinerator Revised 3-08

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Recovery Profiles of Molybdate Solutions Through Varying Dowex TM -1 Resin Amounts, and Translation to Mo99/Tc99m Separation

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

PRODUCTION OF COBALT-60 IN PARR-1/KANUPP (CANDU) Mushtaq Ahmad Isotope Production Division, PINSTECH, Islamabad

Overview of USP Activities and How to Get Involved

Product Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex

AW-Information sheet Authorisation documentation for radiopharmaceuticals NAS

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

PyroSense PAT for WFI By Ken Nichols and Maribeth Donovan Janke

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products

MICROBIOLOGICAL BEST LABORATORY PRACTICES USP <1117>

GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART 1

S U M M AR Y O F P R O D U C T C H AR AC T E R I S T I C S

PHCT 401 Aseptic Processes & Techniques

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

Review Validation of aseptic processes for pharmaceuticals

Analytical and formulation attributes

Required Documentation for PA State (Chapter 252) Accreditation

Republic of the Philippines Department of Health OFFICE OF THE SECRETARY M a n i l a

Compounding Pharmacies and the Contract Testing Lab

SA 450/60 Material Data Sheet

European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe

Radioisotope Production Utilizing HANARO Reactor in KAERI

Characterization and Quality Control Analysis of 99m Tc-Bicisate

Available online at ScienceDirect. Procedia Engineering 132 (2015 )

Technical Reports SeriEs No. 47i. Cyclotron Produced Radionuclides: Guidelines for Setting Up a Facility

USEPA Membrane Filtration Method Method m-tec. Scope and Application: For potable water, nonpotable water, recreation water and wastewater.

AccuPrep 96 Genomic DNA Extraction Kit Cat. No.: K

PHARMACEUTICAL TESTING

Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations

Millistak+ Pod carbon depth filter media system

Management Team. Over 35 years experience in the pharmaceuticals industry

Applying Cleaning Validation Principles in the Manufacture of Medical Devices and Diagnostics August 20, 2014 IVT San Diego

EU and FDA GMP Regulations: Overview and Comparison

Validation Guide USTR 2114 (2) Validation Guide for Pall Emflon PFR Filter Cartridges

Conducting Supplier Audits: Ensure Validation Compliance

OREGON HEALTH & SCIENCE UNIVERSITY RADIATION SAFETY OPERATING PROCEDURE 1101 LABORATORY RADIATION SURVEY

USP CHAPTER <797> INTRODUCTION RISK LEVELS

Spin Micro DNA Extraction Kit

Tests to Support Sterility Claim. Imtiaz Ahmed

Quality is Our Promise.

WM2012 Conference, February 26 March 1, 2012, Phoenix, Arizona, USA

Setting up the Medical Cyclotron Facility at Cochin, Kerala. M.R.A. Pillai Ph.D; D.Sc Molecular Cyclotrons Ltd. Cochin

Transcription:

QUALITY CONTROL AND ASSURANCE OF Tc-99m GENERATORS AND KITS APPLIED IN SAEC LABORATORIES ry-i -y A QGTKTT7 ' '"'' 11111111111 11111 111"»! 111M «Division Radioisotopes, Department of Chemistry, SAEC, Damascus, Syrian Arab Republic Abstract A briefe description of quality assurance and quality control system applied in SAEC laboratories for production of" 1 " Tc- radiopharmaceuticals, is provided. The system includes documentation, procedures, releasing of the products and responsibilities. The system described here undergoes a continues development. INTRODUCTION Syrian Atomic Energy Commission had established a laboratory for production of Tc-99m Kits and generators in order to cover the demands of local hospitals. The products of this laboratory such as MDP, DTPA and PHYTATE kits and the eluate of the produced generators, are used in human being for diagnostic purposes, there fore any impurities or undesired forms of complexes which might affect the human health, image quality or localization of the radionuclides in the target organs should be controlled. in other word, in order to insure the efficacy and safety of products, several factors affect the quality should be controlled during preparation process and several properties should be tested after preparation. Precaution is taken to insure that all steps of process are carried out in accordance with the rules of GMP and GRP. In order to achieve the requirements of the quality, a severe quality assurance system should be established and implemented. Such system should be written and revised by responsible persons and all the procedures to be applied and records of all relevant data must be documented. 719

THE ESTABLISHED QUALITY ASSURANCE SYSTEM DESCRIPTION OF THE SITUATION The radiopharmaceutical laboratory in SAEC has been designed and established in Cooperation with IAEA, where the rules for GRP were considered in the design and installation process. The area of the laboratory is about 100m 2 which is divided in to three major parts which are: kit preparation, generator production and quality control laboratories. The kit preparation lab consists of: clean room with LAF cabinet insuring class 1 environment, freeze drier, balances and filtration devices, laboratory for preparation of glassware and chemicals which contains equipments such as autoclave, ph meters, ultrasonic cleaners..., All spaces related to this lab. are considered controlled area. Tc-99m generator laboratory contains: two hot cells which are provided with accessories and UV lamps for sterilization, in order to ensure higenity of internal environment, radio chemical hoods, isotope calibrator, working bench's, LAF for preparation of cold generator before loading it with Mo-99 in hot cell. The quality control laboratory consists of radiochemical purity, sterility and pyrogenity tests, chemical purity test labs which contains gamma spectroscopy isotope calibrator, LAF cabinet, incubator and equibments for chromatography. Quality is defined in different ways, but here we consider the quality as that products should satisfy the requirements specified by international standards. Quality assurance is defined in the guide of GMP as:' 'the sum total of the organized arrangements made by the object of ensuring that products will be of the quality required by their intended use." Quality control therefore can be defined in this context as" the verification of the quality of products to satisfy the predefined standard specification" then the products can be accepted or refused according to these verifications. 720

Hence the quality assurance system specified in our laboratories consider xxll USP as standard specifications, and the quality control programme applied is a conformity control. The system of quality assurance consider all procedures from receiving raw materials to releasing final products, with emphasis on the qualifications and safety of the staff involved in the preparation and quality control process as, in accordance with guides of GMP and GRP, in order to ensure good quality products. The most important steps involve: - Disinfection of premises, glassware. And equipment's. - Calibration and verification of instrument in use. -Testing of chemicals and raw materials. - Documentation of procedures and records. - Determination of responsibilities. DOCUMENTATION The Standard procedures for all aspects starting with cleaning and disinfecting processes, preparation, QC.. ending and releasing of final products are described in written forms and documented with related records. The Records for all procedures should be signed by the persons involved. All QC Mecords should be signed by QC manager and the certificate of releasing the product should be signed by quality control manager and the head of the laboratory. About 10 procedures and about 30 records are specified for the preparation and quality control of the Kits. Also similar numbers of procedures and records are expected for generators production. THE QUALITY CONTROL SCHEME FOLLOWED IN THE LABORATORY As mentioned before the radio pharmaceutical production laboratory in SAEC has been designed and established in co-operation with IAEA guide lines of GRP considered in the design and installation process. Although all procedures are carried out according to predescribed 721

procedures and all necessary precautions are considered during preparation process, products are undergone tests for quality with accordance to specified procedure and the results of these tests are compared with defined limits(standards) in order to confirm the validity of the products (conformity tests). Both prepared Kits and generators are undergone specified tests where they share some of them and here we will review each of them. Freeze-dried Kits are sealed under vacuum and them they are tested for physical chemical and radio chemical purities. Then the investigations are continue for sterility, pyrogenity and biodistribution in rats. In very rare cases bioscan investigations are carried out on rabbit. The main tests applied for quality control for generators are: the performance, the elution efficiency, the Mo-99 break through, the radionuclidic purity, the chemical purity, the radiochemical purity, physical purity, as well as sterility and pyrogenity. Physical properities include appearance, color and ph value. Chemical purity in the Kits concentrate on the stannious content and in the eluate of generators concentrate on the alumina and (sodium chloride) contents. Stanious is determined iodometrically while aluminum is determiened by complexing with chromazurol-s. Radiochemical purity for both Kits and generators eluates. are investigated using ascending chromatography, where the proportions of pertechnitate, hydrolyzed reduced technetium and technetium complexes are determined and compared with the allowed limits. Biodistribution of the Tc-99m labeled complexes in rat were investigated by intravenous injection of about technetium complexes are determined and compared with the allowed limits. Biodistribution of the Tc-99m labeled complexes in rat were investigated by intravenous injection of about 0.1-0.5 mci of Tc-99m in the tail. After about two hours from the injection the rat is scarified and the relevant organs are counted in fixed geometry. The biodistribution is calculated as the ratio of the activity in the organ to the total activity. In the case of DTP A Kits, the rat is counted after one hour from the injection and after one day, then the rat is scarified and the relevant organs are counted. 722

Sterility measures are considered for all steps of preparation by sterilization of all equipments and reagents in use, but also further tests are carried out on the final products. The sterility tests were carried out using two media which are fluid thioglycolate and Soya bean casein. Incubation is carried out for two weeks at 35C for FTM and at 25C for SCD. Negative results indicate the sterility of the products. Test for pyrogen is carried out using limulus amebocyte lysate (LAL) test where positive and negative standards are used for comparison. Radionuclidic purity of generators eluate and the Mo-99 breakthrough are assayed using a precalibrated gamma spectroscopy while the efficiency of the generator is determined using isotope calibrator. CONCLUSION As mentioned above quality of control Tc-99m radiopharmaceuticals and generators produced in SAEC laboratories undergoes long series of tests to ensure their validity for human use. The overall system of quality assurance applied also undergoes continuos development via research and training in order to keep our products competitive with others. REFERENCES 1- IAEA, preparations of kits for Tc-99m radiopharmaceuticals Tec. Doc-649,1992 2- US. Pharmacopoeia xx II. 3- A. Theobald (ed.)- Radiopharmaceuticals using radioactive compounds in pharmaceutics and Medicine, Ellishorwood Ltd. 1992 4- MJ.welch (ed.)radiopharmaceaticals and other compounds labeled with shortlived radionuclides, pergareon 1977 UEXT PA@E{ ) I I toft BLANK I Ur^^M--1 723